Pediatric pulmonary arterial hypertension: global epidemiology and disease burden during the period 1990 to 2021
Globally, prevalence, mortality, and DALYs of pediatric PAH show a declining trend from 1990 to 2021. Females exhibited higher incidence and prevalence rate but lower mortality and DALYs. 10-14 years had the highest prevalence, whereas high PAH-related mortality in neonates remains a critical concern. Tailored health policies for PAH management are needed.
Authors
- Chenghong Li (ORCID: https://orcid.org/0009-0004-0604-7421)
- Fajiu Li (ORCID: https://orcid.org/0000-0002-1696-7297)
- Rongguo Zhang (ORCID: https://orcid.org/0000-0001-6566-8843)
- Zhongmei Wen
- Ying Chen (ORCID: https://orcid.org/0000-0002-2688-8736)
- Xiaobei Wang (ORCID: https://orcid.org/0000-0003-0929-4124)
- Yongxiao Zheng
Institutions
- Shandong University (CN)
- Jilin University (CN)
- First Hospital of Jilin University (CN)
- Wuhan Sixth Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.3389/fcvm.2025.1544545
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hubei Province